The Pharma Letter1h
Dewpoint and ConcertAI reveal first phase of translational oncology partnership
Dewpoint Therapeutics and ConcertAI have announced the first phase of their translational oncology partnership, aligned ...
BioTechniques11d
Biotech bi-weekly: New bioink for light-based bioprinting, evolving software for drug discovery, mass photometry and multiomics data analysis
Get the last 2 weeks biotech industry news in this quick roundup of the last fortnight's products, people and partnerships ...
labiotech4d
Top biotech deals of November 2024
November 2024 has seen a variety of biotech deals take place to advance therapies across different stages in development.
Dimension raises $500M second fund for investing at the intersection of tech and life sciences
Many VCs, particularly newer firms, readily admit that 2024 has been a challenging year for raising fresh capital. Dimension ...
Dewpoint Therapeutics and ConcertAI Announce the First Phase of their Translational Oncology Partnership
Supporting Dewpoint’s novel condensate modulating approach to drug previously ‘undruggable’ therapeutic targets, guided by ...
Medera’s Novoheart Releases Latest Cardiac Screening Innovation CTScreen v1.5 to Advance High-Throughput, Automated Human-Based Drug Testing
Innovation installed by AstraZeneca for advancing human heart-based R&D for investigational cardiovascular therapiesFeatures improved ...
3 Penny Stocks With 10% to 210% Upside Potential
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
GEN11d
Super-Resolution Microscopy More Than Pretty Pictures
Nanoscopy technology can drive biological discovery not just with imagery, but also with meaningful quantitative data.
Insider Monkey on MSN4d
Recursion Pharmaceuticals’ (RXRX) AI-Driven Cancer Treatment Shows Promise in Early Trials
It also recently announced its LOWE Drug Discovery Software, a language model designed to streamline ... with rapid ...